Maze Therapeutics, Inc.

NASDAQ:MAZE

Biotechnology

Healthcare
$32.43 +0.74%

+$0.18 today

Market cap
$1.77B
Beta
2.26
P/E (TTM)
-11.0
EPS (TTM)
-$2.27
52W Low $9.83High $53.65

Volume 1.00M

Average 0.84M

Balance Sheet

Inspect the capital base behind the business.

Assets

$397.13M

FY 2025 · Annual

+65.1% YoY

Liabilities

$42.16M

FY 2025 · Annual

-3.4% YoY

Equity

$354.97M

FY 2025 · Annual

+80.3% YoY

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents99.92M29.16M196.81M189.25M
Short-term Investments000152.67M
Net Receivables0000
Inventory0000
Other Current Assets6.23M4.95M4.86M7.8M
Total Current Assets106.15M34.11M201.67M349.72M
Property, Plant & Equipment (Net)41.23M34.98M29.92M25.16M
Goodwill0000
Intangible Assets0000
Long-term Investments1.21M1.09M1.09M18.11M
Tax Assets0000
Other Non-current Assets1.37M1.32M7.87M4.14M
Total Non-current Assets43.81M37.39M38.87M47.41M
Total Assets149.96M71.5M240.54M397.13M
Account Payables1.59M2.02M1.94M1.79M
Short-term Debt0000
Tax Payables0000
Deferred Revenue0000
Other Current Liabilities7.49M2.93M6.02M10.85M
Total Current Liabilities20.78M16.32M20.67M22.56M
Long-term Debt020.08M00
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities01969K1.09M
Total Non-current Liabilities27.73M45.13M22.97M19.61M
Total Liabilities48.51M61.45M43.64M42.16M
Common Stock21K22K2K49K
Retained Earnings(295.27M)(395.69M)(358.43M)(489.55M)
Accumulated OCI000110K
Other Stockholders Equity0000
Minority Interest0000
Total Equity101.44M10.05M196.9M354.97M
Total Debt32.06M49.62M26.63M23.31M
Net Debt(67.86M)20.47M(170.18M)(165.94M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$198.8M
Short-term Investments$153.6M
Receivables$20.0M
Other Current$7.4M
Total Current Assets$379.8M
PP&E (Net)$24.0M
Long-term Investments$10.6M
Other Non-current$5.4M
Total Non-current Assets$39.9M
Total Assets$419.7M

Analysis

Selected assets total $419.7M for Latest. The largest visible component is Cash & Equivalents at $198.8M, about 47.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
8-KCurrent reportOct 16, 2026

How much cash does MAZE have?

Maze Therapeutics, Inc. (MAZE) reported $189.25M in cash and equivalents in fiscal 2025.

How much debt does MAZE carry?

Maze Therapeutics, Inc. (MAZE) reported $23.31M of total debt, with net debt of -$165.94M.